Journals / Anadolu Kardiyoloji Dergisi / 2013 / Cilt: 13 - Sayı: 2

Nötrofil/lenfosit oranı kapak hastalığının eşlik etmediği atriyal fibrilasyonda elektriki kardiyoversiyon sonrası nüksü öngördürebilir mi?

Can neutrophil/lymphocyte ratio predict recurrence of non-valvular atrial fibrillation after cardioversion?

Pages
123–130
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: NLR failed to predict AF recurrence after a successful electrical CV, but hs-CRP remained an inflammatory marker of AF recur-rence.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: High neutrophil/lymphocyte ratio (NLR) has been associated with post-operative AF development in patients who underwent cardiac surgery.
📊
Key Findings & Data:Methods: A total of 149 patients who underwent a successful CV were included in this prospective cohort study.
💡
Conclusion & Impact:Conclusion: NLR failed to predict AF recurrence after a successful electrical CV, but hs-CRP remained an inflammatory marker of AF recur-rence.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: High neutrophil/lymphocyte ratio (NLR) has been associated with post-operative AF development in patients who underwent cardiac surgery. In this study, effectiveness of NLR for prediction of recurrence after electrical cardioversion (CV) in non-valvular AF was investigated. Methods: A total of 149 patients who underwent a successful CV were included in this prospective cohort study. Baseline complete blood cell count, routine biochemical tests, high sensitive C-reactive protein (hs-CRP), and echocardiographic measurements were examined. After CV, patients were monitored over six months for recurrence. Baseline characteristics of recurrence group were compared with sinus rhythm group by using Student`s t -test. Logistic regression analysis was used to determine predictors of recurrence. Results: Recurrence occurred in a total of 46 patients (30.9%). Median AF duration [16 (IQR:14.25) vs. 12 (IQR:11) months, p=0.01], baseline hs- CRP [9.80 (IQR: 8.50) mg/dL vs. 4.28 (IQR: 5.65) mg/dL, p=0.002] and left atrium (LA) diameter (4.5±0.4 cm, 4.3±0.5 cm, p=0.023) were significantly higher in the recurrence group than sinus rhythm group. Median NLR was comparable in recurrence and sinus groups [2.38 (IQR: 2.09) vs. 2.23, (IQR: 1.23) p=0.96, respectively]. There was a weak correlation between NLR and hs-CRP (r=0.22, p=0.05) and age (r=0.24, p=0.02). In multiple logistic regression analysis, hs-CRP [OR: 1.34 (1.09-1.65 95% CI) p=0.006], LA diameter [OR: 11.92 (1.84-77.07 95% CI) p=0.01], spontaneous echo contrast positivity, [OR: 5.40 (1.04-12.02 95% CI) p=0.045] and systolic blood pressure [OR: 1.05 (1.01-1.10 95% CI) p=0.03] were independent predictors of AF recurrence. Conclusion: NLR failed to predict AF recurrence after a successful electrical CV, but hs-CRP remained an inflammatory marker of AF recur-rence.

Özet

Amaç: Yüksek nötrofil/lenfosit oranının (NLO) koroner arter baypas cerrahisi sonrası atriyal fibrilasyon (AF) gelişmesiyle ilişkili olduğu gösterilmiştir. Bu çalışmada NLO’nın kapak hastalığının eşlik etmediği AF’de elektriki kardiyoversiyon (KV) sonrası nüksü öngördürmede etkinliği araştırıldı. Yöntemler: Bu prospektif kohort çalışmasına, elektriki KV sonrası başarılı olunan toplam 149 hasta alındı. Tüm hastaların KV öncesi; kişisel bilgileri kaydedildi, tam kan sayımı, alışılagelen biyokimyasal tetkikleri ve yüksek duyarlılıklı C-reaktif protein (hs-CRP) çalışıldı. İşlem öncesi ekokardiyografik ölçümleri kaydedildi. KV sonrası hastalar rekürrens açısından altı ay takip edildi. Nüks gelişen grubun bazal karakteristikleri sinüs grubu ile Student t- testi kullanılarak karşılaştırıldı. Rekürrensin bağımsız öngördürücüleri lojistik regresyon analizi ile araştırıldı. Bulgular: Kırk altı hastada (%30.9) nüks izlendi. Nüks grubunda AF süresi [ortanca: 16 (çeyrekler arası aralık (ÇAA): 14.25]’e karşın, ortanca: 12 (ÇAA: 11) ay, p=0.01) ve sol atriyum (SA) çapı (4.5±0.4 cm’e karşın, 4.3±0.5 cm, p=0.023) belirgin uzun bulundu. Nüks gurubunda, sinus ritmine oranla başlangıç hs-CRP değerleri belirgin yüksek (ortanca: 9.80’e (ÇAA: 8.50) karşın ortanca: 4.28 (ÇAA: 5.65) mg/dL, p=0.002) iken, NLO her iki grupta benzerdi. [rekürrens grubunda ortanca: 2.38 (ÇAA: 2.09), sinüs grubunda ortanca:2.23 (ÇAA: 1.23), p=0.96]. NLO ile hs-CRP seviyeleri (r=0.22, p=0.05) ve yaş (r=0.24, p=0.02) arasında zayıf bir pozitif ilişki mevcuttu. Çoklu lojistik regresyon analizinde hs-CRP [OO: 1.34 (1.09-1.65 %95 GA)] p=0.006) SA çapı [OO: 11.92 (1.84-77.07 %95 GA) p=0.01], spontan eko kontrast varlığı [OO: 5.40 (1.04-12.02 %95 GA) p=0.045] ve sisto- lik kan basıncı [OO: 1.05 (1.01-1.10 %95 GA) p=0.03] nüksün bağımsız öngördürücüleri olarak izlendi. Sonuç: NLO başarılı kardiyoversiyon sonrası AF nüksünü öngördürmede etkisiz bulunmuştur. Hs-CRP başarılı kardiyoversiyon sonrası nüksü öngördürmede etkin olarak kullanılabilir.

🔖

Cite This Article

DUMAN, Ç., GÖK, H., ÖZDEMİR, K., GÜL, E. E., ALİBASİÇ, H., YAZICI, M., KAYRAK, M., AKILLI, H., ARIBAŞ, A., DEMİR, K. (2022). Nötrofil/lenfosit oranı kapak hastalığının eşlik etmediği atriyal fibrilasyonda elektriki kardiyoversiyon sonrası nüksü öngördürebilir mi?. Anadolu Kardiyoloji Dergisi, Cilt: 13 - Sayı: 2, 123–130. https://ajindex.com/articles/436138

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998
  2. [CrossRef] 2. Gronefeld GC, Lilienthal J, Kuck KH, Hohnloser SH. Pharmacological Intervention in Atrial Fibrillation (PIAF) Study Investigators. Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. Eur Heart J 2003
  3. [CrossRef] 3. Spodick DH. Arrhythmias during acute pericarditis. A prospective study of 100 consecutive cases. JAMA 1976
  4. [CrossRef] 4. Bruins P te Velthuis H, Yazdanbakhsh AP Jansen PG, van Hardevelt FW, de Beaumont EM, et al. Activation of the complement system during and after cardiopulmonary bypass surgery: post- surgery activation involves C-reactive protein and is associated with postoperative arrhythmia. Circulation 1997
  5. [CrossRef] 5. Psychari SN, Apostolou TS, Sinos L, Hamodraka E, Liakos G, Kremastinos DT. Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. Am J Cardiol 2005
  6. [CrossRef] 6. Sata N, Hamada N, Horinouchi T, Amitani S, Yamashita T, Moriyama Y, et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart J 2004
  7. [CrossRef] 7. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High- sensitivity C-reactive protein is predictive of successful cardioversion for atrial fibrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006
  8. [CrossRef] 8. Shen XH, Chen Q, Shi Y, Li HW. Association of neutrophil/ lymphocyte ratio with long-term mortality after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Chin Med J 2010
  9. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta 2008
  10. [CrossRef] 10. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G, et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010
  11. [CrossRef] 11. Kaya MG, Akpek M, Elçik D, Kalay N, Yarlioğlueş M,